Cbre Investment Management Listed Real Assets LLC cut its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 2.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,777,769 shares of the real estate investment trust's stock after selling 95,693 shares during the period. Healthpeak Properties accounts for about 1.7% of Cbre Investment Management Listed Real Assets LLC's investment portfolio, making the stock its 16th largest position. Cbre Investment Management Listed Real Assets LLC owned approximately 0.68% of Healthpeak Properties worth $96,845,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Atria Investments Inc raised its stake in shares of Healthpeak Properties by 17.5% in the 4th quarter. Atria Investments Inc now owns 52,516 shares of the real estate investment trust's stock valued at $1,064,000 after acquiring an additional 7,806 shares in the last quarter. Assetmark Inc. raised its stake in shares of Healthpeak Properties by 433.5% in the 4th quarter. Assetmark Inc. now owns 2,982 shares of the real estate investment trust's stock valued at $60,000 after acquiring an additional 2,423 shares in the last quarter. Keybank National Association OH raised its stake in shares of Healthpeak Properties by 36.3% in the 4th quarter. Keybank National Association OH now owns 934,490 shares of the real estate investment trust's stock valued at $18,942,000 after acquiring an additional 248,992 shares in the last quarter. Commerzbank Aktiengesellschaft FI raised its stake in shares of Healthpeak Properties by 3.9% in the 4th quarter. Commerzbank Aktiengesellschaft FI now owns 21,002 shares of the real estate investment trust's stock valued at $420,000 after acquiring an additional 797 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Healthpeak Properties by 0.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 10,153,450 shares of the real estate investment trust's stock valued at $205,810,000 after acquiring an additional 53,392 shares in the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.
Healthpeak Properties Trading Up 1.9 %
Shares of DOC stock traded up $0.39 on Friday, reaching $20.52. 4,462,935 shares of the stock were exchanged, compared to its average volume of 4,746,176. The stock has a market cap of $14.35 billion, a PE ratio of 58.62, a P/E/G ratio of 2.17 and a beta of 1.14. Healthpeak Properties, Inc. has a one year low of $16.66 and a one year high of $23.26. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. The stock has a 50 day moving average price of $20.20 and a 200 day moving average price of $21.30.
Healthpeak Properties Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were given a dividend of $0.305 per share. The ex-dividend date was Friday, February 14th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 5.95%. This is an increase from Healthpeak Properties's previous quarterly dividend of $0.30. Healthpeak Properties's payout ratio is presently 348.57%.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on the company. Wells Fargo & Company cut their price objective on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research note on Tuesday, December 10th. Mizuho lowered their target price on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a report on Thursday, December 5th. Wedbush lowered their target price on Healthpeak Properties from $27.00 to $24.00 and set an "outperform" rating on the stock in a report on Friday, February 14th. Robert W. Baird lowered their target price on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a report on Tuesday, February 11th. Finally, Morgan Stanley raised Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 target price on the stock in a report on Wednesday, January 15th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $23.92.
View Our Latest Report on DOC
Healthpeak Properties Company Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
See Also
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
